MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Protein Degradation and Inhibitors
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

818 results · 1 filter active ·
Results by year
20022025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
818 works in the cohort · of 4,299,418page 11 of 17

Labels cover 1 of 818 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 818 of 818 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Mechanisms that matter: unbiased cellular screening for degraders
Helen E. Burston, Elizabeth M. Rosethorne, Francesca Cavallo, Allan M. Jordan, Prasamit S. Baruah, Denise Swift +1 more
2025· article· en· npj Drug Discovery.· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Publisher Correction: Mechanism of parkin activation by phosphorylation
Véronique Sauvé, George Sung, Naoto Soya, Guennadi Kozlov, Nina Blaimschein, Lis Schwartz Miotto +3 more
2018· erratum· en· Nature Structural & Molecular Biology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Structural Genomics of Human Proteins
Khan Tanjid Osman, A.M. Edwards
2014· article· en· Methods in molecular biology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
afffundunlabeled
Effects of Biguanide-PROTACs in Pancreatic Cancer Cells
Julie Vatté, Véronique Bourdeau, Gerardo Ferbeyre, Andreea R. Schmitzer
2024· article· en· Molecules· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Safety and efficacy of bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients (pts) with relapsed or refractory myelofibrosis (r/r-MF) and other advanced myeloid neoplasms: A phase (Ph) 1 study.
Justin M. Watts, Alessandro M. Vannucchi, Anthony M. Hunter, Vikas Gupta, Srinivas K. Tantravahi, Junichiro Yuda +14 more
2025· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affaboutunlabeled
Abstract LB104: Dose-Finding/Expansion Phase Ib Study to Evaluate the Safety and Activity of BET Inhibitor RO6870810 (RO) and Atezolizumab (A) in Patients (pts) with Advanced Ovarian Cancer (OC) or Triple Negative Breast Cancer (TNBC)
Stéphanie Lheureux, Iben Spangaard, Erika Hamilton, George Au‐Yeung, Debra L. Richardson, Mark DeMario +8 more
2021· article· en· Cancer Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
afffundno abstractunlabeled
Emerging pharmacology of targeted protein degraders
Samir H. Barghout, Mohamed A. Eldeeb
2025· article· en· Journal of Pharmacology and Experimental Therapeutics· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Entdeckung einer chemischen Sonde für MLLT1/3‐YEATS‐Domänen
Moses Moustakim, Thomas Christott, Octovia Monteiro, James M. Bennett, Charline Giroud, Jennifer Ward +19 more
2018· article· de· Angewandte Chemie· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez
Kondababu Kurakula, Olivier Boucherat, Diederik E. van der Feen, Harm Jan Bogaard, Ewelina Kulikowski, Beatrijs Bartelds +4 more
2019· letter· en· American Journal of Respiratory and Critical Care Medicine· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
1
citations

How this was built: Screen · Findings · About